Scarica l'app Stockscreener
20.70
7.69%
1.475
Precedente Chiudi:
$19.22
Aprire:
$19.52
Volume 24 ore:
50,024
Relative Volume:
0.27
Capitalizzazione di mercato:
$295.15M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-2.78%
1M Prestazione:
-3.41%
6M Prestazione:
+10.27%
1 anno Prestazione:
-39.44%
Intervallo 1D:
$19.52
$21.14
Intervallo di 1 settimana:
$18.94
$22.25
Portata 52W:
$6.875
$74.49
Neurogene Inc Stock (NGNE) Company Profile
Nome
Neurogene Inc
Settore
Industria
Telefono
(877) 237-5020
Indirizzo
535 W 24TH STREET, NEW YORK
Confronta NGNE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NGNE
Neurogene Inc
|
20.70 | 290.23M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.45 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.50 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.89 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
645.90 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
303.40 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Neurogene Inc Stock (NGNE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-17 | Iniziato | Craig Hallum | Buy |
| 2025-05-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-06-27 | Iniziato | BMO Capital Markets | Outperform |
| 2024-06-11 | Iniziato | Robert W. Baird | Outperform |
| 2024-04-29 | Iniziato | Leerink Partners | Outperform |
| 2024-03-21 | Iniziato | William Blair | Outperform |
| 2024-01-08 | Iniziato | H.C. Wainwright | Buy |
| 2024-01-05 | Iniziato | Stifel | Buy |
| 2024-01-04 | Iniziato | TD Cowen | Outperform |
Mostra tutto
Neurogene Inc Borsa (NGNE) Ultime notizie
Neurogene Inc. Could See a Relief Rally From Support2025 Performance Recap & Free AI Powered Buy and Sell Recommendations - 선데이타임즈
How to read the order book for Neurogene Inc. [Quarterly Growth Report]Daily Entry Point Alerts - Newser
Neurogene Inc. stock trend outlook and recovery pathBear Market Safe Zone Technical Analysis - Newser
What risks could impact Neurogene Inc. stock performanceMarket Timing Strategy with Technical Filters - Newser
Neurogene Inc. shares fall 5.31% intraday despite positive corporate updates and financial results. - AInvest
Institutional scanner results for Neurogene Inc.Chart-Based Entry Confirmation for Beginners - Newser
Price momentum metrics for Neurogene Inc. explainedInvestment Roadmap for High Potential Stocks - Newser
How to read the order book for Neurogene Inc.Long-Term Stock Growth Forecast Insights - Newser
Neurogene Inc. Reports Increased Losses Amid R&D Focus - TipRanks
How Neurogene Inc. stock performs during market volatilityWeekly High Return Portfolio - classian.co.kr
Neurogene Advances NGN-401 Gene Therapy for Rett Syndrome - TipRanks
Neurogene: Q2 Earnings Snapshot - San Francisco Chronicle
Neurogene Reports Second Quarter 2025 Financial Results and Highlights Recent Updates - Yahoo Finance
Neurogene (NGNE) Files 8-K: Q2 2025 Results Press Release - Stock Titan
Can trapped investors hope for a rebound in Neurogene Inc.Low-Risk Reversal Pattern Analysis Tracker - Newser
How to monitor Neurogene Inc. with trend dashboardsFree Low Risk High Return Opportunities - Newser
Using data models to predict Neurogene Inc. stock movementPrice Action Based Buy Zone Forecast - Newser
Is Neurogene Inc. reversing from oversold territorySummary of Reliable Long-Term Trade Models - Newser
Will Neurogene Inc. bounce back from current supportAI Model Forecasting Reversal and Breakout Zones - Newser
What makes Neurogene Inc. stock price move sharplyDaily Exit and Entry Price Prediction - Newser
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Bank of New York Mellon Corp Acquires 1,844 Shares of Neurogene Inc. (NASDAQ:NGNE) - Defense World
Visual analytics tools that track Neurogene Inc. performanceFree Risk Controlled Short Term Trade Plans - Newser
Neurogene Inc. Moves Into Bullish Territory Based on MACDFast Gaining Stock Screener Reports Released - metal.it
What is the risk reward ratio of investing in Neurogene Inc. stockFree Bull & Bear Market Updates - Jammu Links News
Is Neurogene Inc. stock overvalued or undervaluedUnlock powerful stock screening tools today - Jammu Links News
What drives Neurogene Inc. stock priceUnlock powerful market trend analysis - Jammu Links News
How strong is Neurogene Inc. company’s balance sheetTrack high-yield stocks before they peak - Jammu Links News
How volatile is Neurogene Inc. stock compared to the marketUnlock daily trading alerts for profits - Jammu Links News
What are Neurogene Inc. company’s key revenue driversBuild your wealth with consistent stock growth - Jammu Links News
What analysts say about Neurogene Inc. stockAchieve rapid portfolio growth with expert help - Jammu Links News
Is it the right time to buy Neurogene Inc. stockFree Stock Market Trend Analysis - Jammu Links News
What are analysts’ price targets for Neurogene Inc. in the next 12 monthsMaximize portfolio growth with strategic plans - Jammu Links News
What markets is DRTSW expanding into Is Neurogene Inc. stock a good long term investment optionAchieve breakthrough profits with smart strategies - Jammu Links News
What are the latest earnings results for Neurogene Inc.Identify undervalued stocks poised to rally - Jammu Links News
Neurogene Inc. stock retracement – recovery analysisSmart Trend Analysis With Buy Point Cues - Newser
Can machine learning forecast Neurogene Inc. recoveryFree Fast Gaining Stock Screener Report - Newser
Chart based analysis of Neurogene Inc. trendsIntraday Signal Forecast for Fast Traders - Newser
Neurogene (NGNE) to Release Earnings on Friday - Defense World
Order flow analysis tools used on Neurogene Inc.Short-Term Price Breakout Signal Analysis - Newser
Ranking Neurogene Inc. among high performing stocks via toolsConsistent Profit Signals with AI Models - Newser
What institutional investors are buying Neurogene Inc. stockDaily Trading Review That Work - Jammu Links News
Neurogene Inc Azioni (NGNE) Dati Finanziari
Non sono disponibili dati finanziari per Neurogene Inc (NGNE). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.85%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):